Cardiology

Prospective evaluation of autoimmune and non-autoimmune subclinical hypothyroidism in Down syndrome children.


Related Articles

Prospective evaluation of autoimmune and non-autoimmune subclinical hypothyroidism in Down syndrome children.

Eur J Endocrinol. 2020 Jan 01;:

Authors: Pepe G, Corica D, de Sanctis L, Salerno M, Faienza MF, Tessaris D, Tuli G, Scala I, Penta L, Alibrandi A, Pajno GB, Aversa T, Wasniewska M

Abstract
OBJECTIVE: to evaluate the prevalence and natural course of autoimmune and non-autoimmune subclinical hypothyroidism (SH) in Down syndrome (DS) children and adolescents.
DESIGN: prospective multicenter study.
METHODS: 101 DS patients with SH (TSH 5-10 mIU/L; FT4 12-22 pmol/L), aged 2-17 years at SH diagnosis were enrolled. Annual monitoring of TSH, FT4, BMI, height, L-thyroxine dose was recorded for 5 years. Thyroid autoimmunity was tested at diagnosis and at the end of follow-up.
RESULTS: 37/101 patients displayed autoantibodies positivity (group A); the remaining 64 were classified as non-autoimmune SH (group B). Group A was characterized by higher median age at SH diagnosis and by more frequent family history of thyroid disease (6.6 vs 4.7 years, p=0.001; 32.4% vs 7.8%, p=0.001 respectively), whereas congenital heart defects were more common in group B (65.6% vs 43.2%, p=0.028). Gender, median BMI (SDS), height (SDS), FT4 and TSH were similar in both groups. At the end of follow-up: 35.1% of group A patients developed overt hypothyroidism (OH) vs 17.2% of group B (p=0.041); 31.25% of group B vs 10.8% of group A became biochemically euthyroid (p=0.02); 37.8% of group A vs 51.5% of group B still had SH condition (p=0.183). Logistic regression suggested autoimmunity (OR=3.2) and baseline TSH values (OR=1.13) as predictive factors of the evolution from SH to OH.
CONCLUSIONS: In DS children, non-autoimmune SH showed higher prevalence and earlier onset. The risk of thyroid function deterioration over time seems to be influenced by thyroid autoimmunity and higher baseline TSH values.

PMID: 31999620 [PubMed – as supplied by publisher]

Source link

Related posts

Heart Rate Recovery: A Simple and Powerful Predictor of Mortality Now Available On Your Apple Watch

Newsemia

How “Diabetes Reversal” Works

Newsemia

Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World